Publication | Open Access
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma
38
Citations
20
References
2021
Year
ClinicalTrials.gov Identifier: NCT01572480.
| Year | Citations | |
|---|---|---|
Page 1
Page 1